Galectin Expression Profiling Identifies Galectin-1 and Galectin-9Δ5 as Prognostic Factors in Stage I/II Non-Small Cell Lung Cancer

Approximately 30–40% of the patients with early stage non-small cell lung cancer (NSCLC) will present with recurrent disease within two years of resection. Here, we performed extensive galectin expression profiling in a retrospective study using frozen and paraffin embedded tumor tissues from 87 sta...

Descripción completa

Detalles Bibliográficos
Autores principales: Schulkens, Iris A., Heusschen, Roy, van den Boogaart, Vivian, van Suylen, Robert-Jan, Dingemans, Anne-Marie C., Griffioen, Arjan W., Thijssen, Victor L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2014
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4178059/
https://www.ncbi.nlm.nih.gov/pubmed/25259711
http://dx.doi.org/10.1371/journal.pone.0107988

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4178059/
https://www.ncbi.nlm.nih.gov/pubmed/25259711
http://dx.doi.org/10.1371/journal.pone.0107988

Ejemplares similares